Effect of Atorvastatin on Endothelial Function in Patients with Familial Hypercholesterolemia

Kardiologiya

Volumn 42, Issue 1, 2002, Pages 15-21

  Balakhonova, T V ^b   Pogorelova, O A ^b   Susekov, A V ^b   Kobylyansky, A G ^b   Kuznetsova, T V ^b   Tvorogova, M G ^b   Masenko, V P ^b   Titov, V N ^b   Kukharchuk, V V ^b   Atkov, O Yu ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b NONE

Author keywords

Atorvastatin; Brachial artery; Endothelial function; Hypercholesterolemia; Nitric oxide; Nitrite nitrate; Ultrasound

Indexed keywords

ATORVASTATIN; HEPTANOIC ACID DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; PYRROLE DERIVATIVE;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG EFFECT; FEMALE; GENETICS; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; VASCULAR ENDOTHELIUM;

ADULT; ANTICHOLESTEREMIC AGENTS; ENDOTHELIUM, VASCULAR; FEMALE; HEPTANOIC ACIDS; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PYRROLES;

EID: 0142011257     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Celennajer D.S., Sorensen K.E., Gooch V.M. et al. Non-invasive detection of endothelial dysfunction in children and a dults at risk of atherosclerosis. Lancet 1992;340:1111-1115.
2. Stores E., Rabelink T.J. Hyperlipidemiaand endothelial function.In: Vascular endothelium. Physiology, pathology, and therapeutic opportunites. Eds. G.V.R. Bom, C.J. Schwartz. Stuttgart-New York: Schattauer 1998;311-328.
3. Wever R., Stores E., Rabelink T.J. Nitric oxide and hypercholesterolemia: a matter of oxidation and reduction? Atherosclerosis 1998;137:Suppl: S51-S60.
4. Luscher T.F., Tanner F.C., Noll G. Lipids and endothelial function: effects of lipid-lowering and other therapeutic interventions. Curr Opin Lipid 1996;7:234-240.
5. Celermajer D.S., Sorensen K.E., Georgakopoulos D. et al. Cigarette smoking is associates with dose-related and potentially reversible impairement of endothelium-dependent dilatation in healthy young adults. Circulation 1993;88:2149-2155.
6. Celermajer D.S., Sorensen K.E., Rayyls M. et al. Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in theor heterozygous parents. J Am Coll Cardiol 1993;22:854-858.
7. Sorensen K.E., Celermajer D.S., Georgakopoulos D. et al. Impairement of endothelium-dependent dilatation is an early event in children with familial hypercholesterolemia, and is related to the Lp(a) level. J Clin Invest 1994;93:50-55.
8. th Annual Scientific Session. Anaheim (CA United States) 2000.
9. Schwartz G.G., Oliver M.F., Ezekowitz M.D. et al. Rationale and design of the myocardial ischemia erduction with aggressive cholesterol lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction. Am J Cardiol 1998;81:578-581.
10. Vita A.J., Yeung A.C., Winniford M. et al. Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease. Circulation 2000;102: 846-851.
11. Dupuis J., Tardif J.C., Cernacek P., Theroux P. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. Circulation 1999;99:3227-3233.
12. Lubrano V., Vassalle C., Franzoni F. et al. Relation between lipid peroxidation and vascular nitric oxide production in endurance athletes and hypercholesterolemic patients before and during atorvastatin therapy. Eur Heart J 2000;21:Suppl:Abstract:153.
13. Tanaka S., Yashiro A., Nakashima Y. et al. Plasma nitrite/nitrate level is inversely correlated with plasmalow-density lipoprotein cholesterol level. Clin Cardiol 1997;20:361-365.
14. Sorensen K.E., Celermajer D.S., Spiegelhalter D.J. et al. Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J 1995;74:247-253.
15. Wendelhad I., Gustavsson T., Suurcula M. et al. Ultrasound measurement of wall thickness in carotid artery: fundumental principles and description of computerised analysis system. Clin Physiol 1991;11:565-577.
16. Salonen R., Salonen J.T. Determinants of carotid intima-media thinkness: a population based ultrasonography study in Eastern Finnish men. J Intern Med 1999;229:225-231.
17. Simons L.A., Sullivan D., Simons J., Celennajer D.S. Effect of atorvastatin monotherapy and simvastatin plus cholesteramine on arterial endothelial function in patients with severe primary hypercholesterolaemia. Atherosclerosis 1998;137:197-203.
18. Jones P., Kafonek S., Laurora I., Hunninghiake D. for the CURVES Investigators. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastating and fluvastatin in patients with hypercholesterolaemia (the CURVES Study). Am J Cardiol 1998;81:582-587.
19. Crouse J.R., Kastelein J., Isaacson J. et al. A large, 36 week study of the HDL-C raising effects and safety of simvastatin versus atorvastatin. International Simposium in Atherosclerosis, 12-th: Abstracts. Atherosclerosis 2000;151:8.
20. Uehata A., Gerhard M.D. et al. Close relationship of endothelal dysfunction in coronary and brachial artery. Circulation 1993;88: 1-618.
21. Sorensen K.E., Kristensen I.B., Celermajer D.S. Atherosclerosis in the human brachial artery. J Am Coll Cardiol 1997;29:318-322.
22. Zeiher A.M., Schachninger V., Saurbier V.B., Just H. Assessment of endothelial modulation of coronary vasomotor tone: Insights into a fundamental functional disturbance in vascular biology of atherosclerosis. In: Arteriosclerosis: new insights into pathogenetic mechanisms and prevention. Eds. H. Just, W. Hort, A.M. Zeiher. New York: Springer-Verlag 1994;115-128.
23. Neunteufl T., Kostner K., Katzenschlager R. et al. Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholsterolemic men. J Am Coll Cardiol 1998;32:711-716.
24. Anderson T.J., Meredith I.T., Yeung A.C. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. New Engl J Med 1995;332:448-493.
25. Egashira K., Hirooka Y., Kai H. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients hypercholesterolemia. Circulation 1994;89:2519-2524.
26. Leung W.H., Lau S.P., Wong C.K. Beneficial effect of cholsterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet 1993;341:1496-1500.
27. O'Driscoll G., Green D., Taylor R.R. Simvastatin, and HMG-coenzyme A reductase inhibitor, improves endothelial function with 1 month. Circulation 1997;95:1126-1131.
28. Pogorelova O.A., Balahonova T.V., Laguta P.S. Fluvastatin improves flow-mediated dilatation of the brachial artery in patients with established atherosclerosis. In: Book of abstracts 11 EUROSON-Congress. Berlin 1999;11.
29. Treasure C.B., Klein J.L., Weintraub W.S. et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. New Engl J Med 1995;332: 481-487.
30. Ohara Y., Peterson T.E., Sayegh H.S. et al. Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circulation 1995;92:898-903.
31. Laiudef L., Soriano F.G., Szabo C. Biology of nitric oxide signaling. Crit Care Med 2000;28:Suppl: 37-52.
32. Vaughan C.J., Murphy M.B., Buckley B.M. Statins do more just lower cholesterol. Lancet 1996;348:1079-1082.
33. Smilde T.J., van den Berkmortel F.W., Wollersheim H. et al. The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolaemia. Eur J Clin Invest 2000;30:473-480.
34. Spacil J., Ceska R., Petrasek J., Sobra J. The effect of four-year hypolipidaemic treatment on the intimal thickness of the common carotid artery in patients with familiae hyperlipidemia. Int Angiol 1999;18:313-319.